Indivior Sues Teva, Others Over Opioid Addiction Generics

Law360 (February 9, 2018, 6:55 PM EST) -- Indivior Inc. has filed several suits in New Jersey and Utah federal courts accusing Teva Pharmaceutical Inc., Actavis Laboratories UT Inc. and others of infringing a patent Indivior holds for Suboxone sublingual film, a drug used to treat opioid addiction.

U.K.-based Indivior filed three complaints in New Jersey on Feb. 7 against Teva Pharmaceutical, Par Pharmaceutical Inc. and Dr. Reddy's Laboratories SA and a complaint in Utah against Actavis over the four companies’ proposed generic versions of Suboxone.

The suits, also brought by Indivior’s partner Aquestive...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.